Literature DB >> 12812757

Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord.

Maryline Sicotte1, Ourania Tsatas, Suh Young Jeong, Chuan-Qi Cai, Zhigang He, Samuel David.   

Abstract

We have shown previously that immunization with myelin in incomplete Freund's adjuvant (IFA) is able to promote robust regeneration of corticospinal tract fibers in adult mice. In the present study the effectiveness of such immunization with myelin was compared to that of a combination of two axon growth inhibitors in myelin, Nogo-66 (the 66-amino-acid inhibitory region of Nogo-A) and myelin-associated glycoprotein (MAG). The effectiveness of two adjuvants, IFA and aluminum hydroxide (Alum), was also compared, the latter being one that can be used in humans. In addition, larger dorsal overhemisections were made at the lower thoracic level, which resulted in a larger scar. These studies were carried out in SJL/J mice, a mouse strain that is susceptible to autoimmune experimental allergic encephalomyelitis (EAE). None of the immunized mice developed EAE. Long-distance axon regeneration and sprouting of the corticospinal tract was seen in myelin and Nogo-66/MAG immunized mice. Alum was as effective or better than IFA as the adjuvant. Overall, the robustness of axon growth and sprouting was greater in mice immunized with myelin. The abundance of this growth was less than in our earlier work in which smaller lesions were made, pointing to the possible influence of inhibitors in the scar. This work shows, however, that axon growth inhibitors in myelin can be selectively blocked using this immunization approach to promote long-distance axon regeneration in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812757     DOI: 10.1016/s1044-7431(03)00053-8

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  21 in total

1.  The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.

Authors:  Karthik Venkatesh; Onanong Chivatakarn; Hakjoo Lee; Pushkar S Joshi; David B Kantor; Barbara A Newman; Rose Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

2.  Sialidase enhances spinal axon outgrowth in vivo.

Authors:  Lynda J S Yang; Ileana Lorenzini; Katarina Vajn; Andrea Mountney; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

Review 3.  Neurobiology of rehabilitation.

Authors:  Bruce H Dobkin
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

4.  Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage.

Authors:  Robert E Ayer; Robert P Ostrowski; Takashi Sugawara; Qingy Ma; Nazanin Jafarian; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2013

Review 5.  Role of myelin-associated inhibitors in axonal repair after spinal cord injury.

Authors:  Jae K Lee; Binhai Zheng
Journal:  Exp Neurol       Date:  2011-05-07       Impact factor: 5.330

Review 6.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

7.  Therapeutic DNA vaccination as a repair strategy following spinal cord injury.

Authors:  Sheng-Bin Kou; Gang Xu; Xiao-Dan Jiang; Ru-Xiang Xu; Yan-Ping Tang; Gang Xu; Ying-Qian Cai; Mou-Xuan Du; Zhi-Cheng Xiao
Journal:  Cell Mol Neurobiol       Date:  2009-09-16       Impact factor: 5.046

8.  Regenerative growth of corticospinal tract axons via the ventral column after spinal cord injury in mice.

Authors:  Oswald Steward; Binhai Zheng; Marc Tessier-Lavigne; Maura Hofstadter; Kelli Sharp; Kelly Matsudaira Yee
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

Review 9.  Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.

Authors:  MirHojjat Khorasanizadeh; Mahsa Eskian; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 10.  Basic advances and new avenues in therapy of spinal cord injury.

Authors:  Bruce H Dobkin; Leif A Havton
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.